文献速递头颈与中枢神经肿瘤

头颈部鳞状细胞癌选择性单侧颈部照射:范式的转变

Elective unilateral nodal irradiation in head and neck squamous cell carcinoma: A paradigm shift.
PubMed 文献 · Eur J Cancer · 2017-06-19

本文基于11项已发表研究共1116例患者的数据,汇总分析头颈部鳞状细胞癌(HNSCC)行单侧颈部照射后对侧区域失败(cRF)的发生率。口咽癌单侧照射患者cRF发生率为2.4%,肿瘤累及中线者发生率更高(12.1%)。作者认为,当前诊断影像技术下,对经过良好选择的侧化性HNSCC患者行单侧选择性颈部照射是合理的,可减少放疗相关毒性并改善生活质量。

要点

  • 口咽癌单侧颈部照射患者cRF发生率为2.4%,肿瘤累及中线者为12.1%。
  • 汇总11项研究共1116例患者数据,支持对良好选择的侧化性HNSCC行单侧选择性颈部照射。
  • 作者认为当前诊断影像技术进步有助于筛选适合单侧照射的患者,减少放疗毒性。

核心结论

  • 基于11项研究共1116例患者的汇总数据,对经过良好选择的侧化性HNSCC患者行单侧选择性颈部照射是合理的。

研究设计与样本

  • 本文汇总分析了11项已发表研究,共纳入1116例接受单侧颈部照射的头颈部鳞状细胞癌患者。

主要发现

  • 口咽癌接受单侧颈部照射的患者中,对侧区域失败(cRF)的发生率为2.4%。
  • 肿瘤累及中线的患者cRF发生率更高,为12.1%。
  • 接受局部切除联合单侧颈淋巴结清扫或前哨淋巴结活检的HNSCC患者中,cRF发生率也较低。

临床怎么用

  • 作者认为,基于汇总数据,放宽单侧选择性颈部照射的患者选择标准是合理的。
  • 作者认为,对于经良好选择、肿瘤侧化且延伸至中线但未跨越中线的HNSCC患者,不必过度担心对侧颈部未治疗。
  • 作者认为,当前明显改进的诊断影像有助于筛选相当比例侧化性HNSCC患者接受单侧选择性颈部照射,从而显著减少放疗相关毒性并改善生活质量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

There is a long-standing convention to irradiate the great majority of head and neck squamous cell carcinoma (HNSCC) electively to both sides of the neck, to reduce the theoretically increased risk of contralateral regional failure (cRF). With the currently available diagnostic imaging techniques this treatment paradigm means, in our opinion, an overtreatment in considerable proportion of these patients. From all the published studies (n = 11, with 1116 patients treated in total), the incidence of cRF in patients with oropharyngeal cancer treated to one side of the neck is 2.4%. The incidence was higher in patients with tumours involving the midline (12.1%). The low incidence of cRF was also seen in patients with HNSCC treated by local excision combined with unilateral neck dissection or sentinel node procedure. It seems clear from the aggregated data of these studies that a less conservative approach with regard to the selection of patients for unilateral elective nodal irradiation is justified. The fear of leaving the contralateral neck untreated in well-selected groups of patients with HNSCC needs nowadays to be mitigated since the incidence of cRF in lateralised tumours extending to but not crossing the midline is low. Furthermore, the obviously improved diagnostic imaging nowadays could help us to guide the selection of considerable proportion of patients with lateralised HNSCC for unilateral elective nodal irradiation with significant reduction of radiation-related toxicity and improved quality of life.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Al-Mamgani A, Verheij M, van den Brekel MWM, et al. Elective unilateral nodal irradiation in head and neck squamous cell carcinoma: A paradigm shift. Eur J Cancer. 2017. PMID: 28633075. doi:10.1016/j.ejca.2017.05.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。